About 200 reports

  • Biguanides
  • List of major brands of biguanides for diabetes

Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases....

  • Antidiabetics
  • Therapy
  • United States
  • Forecast
  • Market Size
  • Global Biguanides Drug Market ,By Value
  • Global Biguanides Drug Market, By Value

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty...

  • Digestive System Disorder
  • Healthcare
  • Pathology
  • World
  • Gilead Sciences, Inc.
  • Biguanides and Amidines 98
  • Biguanides and Amidines 79

• The global market for antiseptics and disinfectants reached $6.4 billion and $6.7 billion in 2015 and 2016, respectively. This market is estimated to reach $9.1 billion in 2022 from nearly $7.1 billion in 2017 at a compound annual growth rate (CAGR) of 5.2% for 2017-2022. • Quaternary ammonium compounds as a segment is expected to grow...

  • Antiseptics
  • Infection Control
  • Medical Supply
  • OTC
  • World
  • Biguanide Disinfectants
  • Biguanide Disinfectants Import

This study focuses on China’s Disinfectants industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Infection Control
  • Medical Supply
  • China
  • Trade
  • Chengdu Minsheng Disinfectant Co.
  • Biguanides Drugs
  • Total Biguanides Production and Demand (million Yuan)

This study focuses on China’s Diabetes Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Antidiabetics
  • Diabetes
  • Insulin
  • China
  • Demand
  • Biguanide Disinfectants Major Producer and Their
  • Biguanide Disinfectants Export Volume and Market

China’s demand for Disinfectants has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Infection Control
  • China
  • Demand
  • Chengdu Minsheng Disinfectant Co.
  • Wuhan Newland EPM Co.
  • 2.9.2.2 Biguanides
  • 12.1 Biguanides Market, 2016

Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others The global diabetes drugs market was valued at $49.26bn in 2016 and is projected to grow at a CAGR of 6.1% in the first half of the forecast period.to reach global revenue of $66.29bn in...

  • Therapy
  • World
  • Market Shares
  • Total Biguanides Production and Demand (million Yuan)
  • Sulfonylurea Production and Demand (million Yuan)

China’s demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Diabetes
  • Insulin
  • Pharmaceutical
  • China
  • Zhejiang Expressway Co., Ltd.
  • Figure 16: Global Surface Disinfectants Market Size (US$ Mn) and Volume (Tons), by Biguanides, 2015–2024
  • Global Surface Disinfectants Market Size (US$ Mn) and Volume (Tons), by Biguanides, 2015–2024

Global Surface Disinfectant Market: Overview Surface disinfectants are chemical compound products used to deactivate or destroy microorganisms from environmental surfaces such as floors, chairs, bench tops, walls and ceilings. Depending upon their chemical composition, they can be segmented into several product types such as...

  • Infection Control
  • Medical Supply
  • World
  • Forecast
  • Market Size
  • 2.13 Most Antiseptic Formulations Comprise Biguanides and Amidines
  • 2.12 Biguanides and Amidines Enable Enhanced Antimicrobial Functions

Novel Microbicidal Platforms Likely to Transform the Future of Global Consumer Health Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections. While...

  • Antiseptics
  • Infection Control
  • Medical Supply
  • OTC
  • World
  • T2D TREATMENTS
  • 12.4.1 DIAGNOSED T2D PATIENTS

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 Summary Type 2 diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic ?-cell failure, with an underlying genetic predisposition heavily influenced by diet and lifestyle (Stumvoll et al., 2010). It is well...

  • Antidiabetics
  • Endocrine Disease
  • Insulin
  • Therapy
  • Type 2 Diabetes
  • DIABETES DRUGS MARKET, GLOBAL, GENERIC USAGE ACROSS KEY INDICATIONS, 2017
  • DIABETES DRUGS MARKET, GLOBAL, T1DM AND T2DM PIPELINE BY STAGE OF

Orally administered drugs such as the biguanide metformin are typically used as first-line therapies for T##DM.

  • Antidiabetics
  • Clinical Trial
  • Diabetes
  • Insulin
  • World
  • Apr 24, 2018: Organogenesis Showcases New Product Offerings and Research at SAWC Spring 2018
  • ADVANCED MEDICAL ENTERS INTO LICENSING AGREEMENT WITH ORGANOGENESIS

" I' m pleased to be joining such a pioneering organization, one that empowers employees to improve patient outcomes, " said Pearl.

  • Medical Device
  • Medical Equipment
  • Medical Supply
  • Wound Care
  • Organogenesis, Inc.
  • Not disclosed
  • ACELITY

IT UTILIZES PURIFIED NATIVE COLLAGEN MATRIX EMBEDDED WITH THE ANTIMICROBIAL POLYHEXAMETHYLENE BIGUANIDE.

  • Molecular Biology
  • Tissue Engineering
  • MiMedx Group, Inc.
  • Organogenesis, Inc.
  • Zimmer Biomet Holdings, Inc.
  • SMALL MOLECULE TO AGONIZE GPR119 FOR TYPE 2 DIABETES - DRUG PROFILE

The drug candidate is a trans-##, ##-dioxycyclohexane.

  • Molecular Diagnostic
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Product Initiative
  • Biguanides
  • BIGUANIDES MARKET, 2016-2023, ($MILLION)

Diabetes Therapeutics Market by Product [Injectables (Insulin, Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Amylinomimetic Drugs) and Oral-antidiabetic Drugs (OAD) (Biguanides, Sulfonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, Dipeptidyl Peptidase IV (DPP-4) Inhibitors, Meglitinides, and Sodium-glucose Cotransporter-2...

  • Antidiabetics
  • Diabetes
  • Therapy
  • World
  • Market Size
  • Biguanides
  • MAJOR PRODUCTS & THEIR SALES IN THE BIGUANIDES DRUG CLASS (USD MILLION) IN 2014

Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. Oral anti-diabetics were the leading category of drugs in 2014 and showed a growth rate of 6.3% from the total global sales. The total sales for insulin...

  • Antidiabetics
  • Diabetes
  • Insulin
  • Pharmaceutical
  • United States
  • Global biocides and disinfectants market by nonoxidizing chemicals segment

You can easily book an appointment with one online.

  • Biocide
  • Infection Control
  • Akzo Nobel N.V.
  • Clariant AG
  • Dow Chemical Company
  • Market segmentation by drug class
  • NON-INSULIN THERAPIES

About Diabetic Therapeutic The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than...

  • Antidiabetics
  • Diabetes
  • Insulin
  • Pharmaceutical
  • Novo Nordisk Group
  • Small Molecule to Agonize GPR119 for Type 2 Diabetes

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Molecular Diagnostic
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Product Initiative
  • 7.1.4 Biguanide
  • Global – Forecast for Oral Drug Biguanide Market (Million US$), 2018 – 2024

Diabetes Drug Market, Oral (DPP IV Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor, Biguanide) Injection (Glucagon-like peptide (GLP) 1 agonist, Amylin Receptor Agonist), Insulin (Rapid – Acting Insulin, Long Acting Insulin, Premixed Insulin), Regions (United States, Europe, Japan, China, India, Brazil), Companies (Novo Nordisk, Merck...

  • Chronic Disease
  • Diabetes
  • Pathology
  • Therapy
  • World
  • CATEGORY
  • Acquisitions

This matrix utilizes a strong biocompatible fenestrated sheet of porcine-derived collagen coated with polyhexamethylene biguanide (PHMB).

  • Healthcare
  • Medical Supply
  • Wound Care
  • North America
  • United States
  • Kissei Pharmaceutical Co Ltd - History

A ratio under ## suggests that the company would be unable to pay off its obligations if they came due at that point.

  • Healthcare
  • Pharmaceutical
  • World
  • Company Financials
  • Kissei Pharmaceutical Co., Ltd.
  • Advanced Medical Solutions Group Plc (AMS)
  • Geographical Segment: United States of America

NHS IS ALSO ONE OF THE LARGEST CONSUMERS OF HEALTHCARE PRODUCTS IN EUROPE.

  • Medical Equipment
  • Medical Supply
  • Wound Care
  • United States
  • Company Financials
  • 4.9.1 Non-Insulin T2DM Therapies
  • Appendix

Metformin is the only biguanide available in the US.

  • Chronic Disease
  • Diabetes
  • Insulin
  • Type 2 Diabetes
  • World
  • Diabetes Drugs Production and Demand (million Yuan)
  • China's Diabetes Drugs Capacity, Output, Demand

This study focuses on China’s Diabetes Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

  • Diabetes
  • Pharmaceutical
  • China
  • Bayer AG
  • Beijing Taiyang Pharmaceutical Group
  • Disinfectants Sales Volume (Million Yuan)
  • CHAPTER III DISINFECTANTS

This study focuses on China’s Disinfectants industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

  • Infection Control
  • China
  • Chengdu Minsheng Disinfectant Co.
  • Wuhan Newland EPM Co.
  • Zhejiang Expressway Co., Ltd.
  • Recent Developments
  • Recent Developments

ON ## SEPTEMBER 2015 WE RECEIVED CE APPROVAL IN EUROPE FOR A NEW NON-ADHESIVE ANTIMICROBIAL FOAM DRESSING CONTAINING POLYHEXAMETHYLENE BIGUANIDE (PHMB).

  • Clinical Trial
  • Medical Supply
  • Wound Care
  • United States
  • Demand
  • 2.9.2.2 Biguanides
  • 12.1 Biguanides Market, 2015

Report Details Treating diabetes – benefit your influence by finding new R&D trends and sales prospects Discover the future of antidiabetic medicines. For those treatments, you will receive diabetes market size and revenue projections. You will learn the future potential by exploring research and development pipelines. And you...

  • Therapy
  • World
  • Market Shares
  • LIST OF ABBREVIATIONS
  • KEYFINDINGS

Increasing demand from healthcare industry and rising awareness towards health and hygiene to drive the antimicrobial textiles market The antimicrobial textiles market is estimated to be valued at USD 7.71 billion in 2017 and is projected to reach USD 10.28 billion by 2022, at a CAGR of 5.9% from 2017 to 2022. Growth of...

  • Materials
  • Textile
  • World
  • Market Size
  • PurThread Technologies, Inc.